First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL ...Middle East

Medscape - News
The study findings add new insights, but also raise new questions, about the best treatment approach for Philadelphia chromosome-positive acute lymphoblastic leukemia. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL )

Apple Storegoogle play

Also on site :